Baseline Immunological Profile in Secondary Progressive Multiple Sclerosis Patients of Phase III EXPAND Trial

被引：0
|
作者：
Mao-Draayer, Yang [1 ]
Wu, Qi [1 ]
Wang, Qin [1 ]
Lundy, Steve K. [1 ]
Dowling, Catherine [1 ]
Segal, Benjamin Matthew M. [1 ]
Fox, David [1 ]
Wallstroem, Erik [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P011
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] Siponimod improves cognitive processing speed in patients with secondary progressive multiple sclerosis: EXPAND subgroup analyses
    Benedict, R.
    Fox, R.
    Tomic, D.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Ritter, S.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 868 - 868
  • [42] Efficacy of Siponimod in secondary progressive multiple sclerosis patients with active disease: the EXPAND study subgroup analysis
    Gold, R.
    Kappos, L.
    Bar-Or, A.
    Vermersch, P.
    Giovannoni, G.
    Fox, R.
    Rouyrre, N.
    Karlsson, G.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 380 - 381
  • [43] Siponimod Improves Cognitive Processing Speed in Patients with Secondary Progressive Multiple Sclerosis: EXPAND Subgroup Analyses
    Benedict, R.
    Tomic, D.
    Fox, R.
    Cree, B.
    Vermersch, P.
    Giovannoni, G.
    Bar-Or, A.
    Gold, R.
    Ritter, Sh.
    Karlsson, G.
    Wolf, C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP20 - NP21
  • [44] How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
    Braune, Stefan
    Bergmann, Arnfin
    Bezlyak, Vladimir
    Adlard, Nicholas
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [45] Cognitive and MRI profile in primary and secondary progressive multiple sclerosis
    Mistri, D.
    Cacciaguerra, L.
    Valsasina, P.
    Pagani, E.
    Filippi, M.
    Rocca, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 156 - 156
  • [46] Evaluation of immunological and clinical parameters in patients with primary progressive and secondary progressive multiple sclerosis: a case control study of 60 patients
    Kitsos, D. K.
    Tsiodras, S.
    Poulios, A.
    Ploubidis, G. B.
    JOURNAL OF NEUROLOGY, 2011, 258 : 200 - 200
  • [47] Trial design and baseline data of the INFORMS (fingolimod in patients with primary progressive multiple sclerosis) study
    Polman, C. H.
    Cree, B.
    Freedman, M. S.
    Hartung, H. -P.
    Holdbrook, F.
    Kappos, L.
    Kornyeyeva, E.
    Lubetzki, C.
    Lublin, F. D.
    Miller, D. H.
    Montalban, X.
    Pirozzi, C.
    Weiner, H. L.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 437 - 438
  • [48] Immunological profile of patients with multiple sclerosis associated fatigue
    Strassburger, K.
    Kumar, M.
    Vago, S.
    Kreuzfelder, E.
    Limmroth, V.
    Putzki, N.
    MULTIPLE SCLEROSIS, 2006, 12 : S64 - S65
  • [49] Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
    Fox, R. J.
    Coffey, C. S.
    Conwit, R.
    Cudkowicz, M. E.
    Gleason, T.
    Goodman, A.
    Klawiter, E. C.
    Matsuda, K.
    McGovern, M.
    Naismith, R. T.
    Ashokkumar, A.
    Barnes, J.
    Ecklund, D.
    Klingner, E.
    Koepp, M.
    Long, J. D.
    Natarajan, S.
    Thornell, B.
    Yankey, J.
    Bermel, R. A.
    Debbins, J. P.
    Huang, X.
    Jagodnik, P.
    Lowe, M. J.
    Nakamura, K.
    Narayanan, S.
    Sakaie, K. E.
    Thoomukuntla, B.
    Zhou, X.
    Krieger, S.
    Alvarez, E.
    Apperson, M.
    Bashir, K.
    Cohen, B. A.
    Coyle, P. K.
    Delgado, S.
    Dewitt, L. D.
    Flores, A.
    Giesser, B. S.
    Goldman, M. D.
    Jubelt, B.
    Lava, N.
    Lynch, S. G.
    Moses, H.
    Ontaneda, D.
    Perumal, J. S.
    Racke, M.
    Repovic, P.
    Riley, C. S.
    Severson, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09): : 846 - 855
  • [50] A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis
    Fox, Robert
    Ashokkumar, Akshata
    Barnes, Janel
    Chase, Marianne
    Coffey, Christopher
    Conwit, Robin
    Cudkowicz, Merit
    Ecklund, Dixie
    Gleason, Trevis
    Goodman, Andrew
    Klawiter, Eric
    Klinger, Elizabeth
    Koepp, Maxine
    Matsuda, Kazuko
    McGovern, Michelle
    Naismith, Robert
    Yankey, Jon
    NEUROLOGY, 2018, 90
12345